-
1
-
-
84875755221
-
-
National Cancer Institute:
-
National Cancer Institute: FDA approval for vincristine sulfate liposome. 2012. http://www.cancer.gov/cancertopics/druginfo/fda-vincristine-sulfate- liposome
-
(2012)
FDA approval for vincristine sulfate liposome.
-
-
-
2
-
-
84875716409
-
High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult philadelphia chromosome-negative acute lymphoblastic leukemia
-
O'Brien S, Schiller G, Lister J, et al: High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia. J Clin Oncol 31:676-683, 2013
-
(2013)
J Clin Oncol
, vol.31
, pp. 676-683
-
-
O'Brien, S.1
Schiller, G.2
Lister, J.3
-
3
-
-
0001025207
-
Clinical studies with vincristine
-
Carbone PP, Bono V, Frei E III, Brindley CO: Clinical studies with vincristine. Blood 21:640-647, 1963
-
(1963)
Blood
, vol.21
, pp. 640-647
-
-
Carbone, P.P.1
Bono, V.2
Frei III, E.3
Brindley, C.O.4
-
4
-
-
0014893444
-
Combination chemotherapy in the treatment of advanced hodgkin's disease
-
Devita VT Jr., Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73:881-895, 1970
-
(1970)
Ann Intern Med
, vol.73
, pp. 881-895
-
-
Devita Jr., V.T.1
Serpick, A.A.2
Carbone, P.P.3
-
6
-
-
0028855939
-
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models
-
Webb MS, Harasym TO, Masin D, et al: Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models. Br J Cancer 72:896-904, 1995
-
(1995)
Br J Cancer
, vol.72
, pp. 896-904
-
-
Webb, M.S.1
Harasym, T.O.2
Masin, D.3
-
7
-
-
72249112336
-
Phase i multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia
-
Thomas DA, Kantarjian HM, Stock W, et al: Phase I multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia. Cancer 115:5490-5498, 2009
-
(2009)
Cancer
, vol.115
, pp. 5490-5498
-
-
Thomas, D.A.1
Kantarjian, H.M.2
Stock, W.3
-
8
-
-
58149394138
-
Outcome of adults with acute lymphocytic leukemia after second salvage therapy
-
O'Brien S, Thomas D, Ravandi F, et al: Outcome of adults with acute lymphocytic leukemia after second salvage therapy. Cancer 113:3186-3191, 2008
-
(2008)
Cancer
, vol.113
, pp. 3186-3191
-
-
O'Brien, S.1
Thomas, D.2
Ravandi, F.3
-
9
-
-
67650584040
-
-
Bethesda, MD, National Cancer Institute
-
Horner MJ, Ries LAG, Krapcho M, et al (eds): SEER Cancer Statistics Review, 1975-2006. Bethesda, MD, National Cancer Institute, 2008
-
(2008)
SEER Cancer Statistics Review, 1975-2006
-
-
Horner, M.J.1
Ries, L.A.G.2
Krapcho, M.3
-
10
-
-
33749599695
-
Chronic health conditions in adult survivors of childhood cancer
-
DOI 10.1056/NEJMsa060185
-
Oeffinger KC, Mertens AC, Sklar CA, et al: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572-1582, 2006 (Pubitemid 44547808)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.15
, pp. 1572-1582
-
-
Oeffinger, K.C.1
Mertens, A.C.2
Sklar, C.A.3
Kawashima, T.4
Hudson, M.M.5
Meadows, A.T.6
Friedman, D.L.7
Marina, N.8
Hobbie, W.9
Kadan-Lottick, N.S.10
Schwartz, C.L.11
Leisenring, W.12
Robison, L.L.13
-
11
-
-
84856214155
-
Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia
-
Ness KK, Hudson MM, Pui CH, et al: Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia. Cancer 118:828-838, 2012
-
(2012)
Cancer
, vol.118
, pp. 828-838
-
-
Ness, K.K.1
Hudson, M.M.2
Pui, C.H.3
|